Equities

PVP Ventures Ltd

PVP Ventures Ltd

Actions
Real EstateReal Estate Investment and Services
  • Price (INR)25.75
  • Today's Change-1.36 / -5.02%
  • Shares traded726.94k
  • 1 Year change+125.88%
  • Beta--
Data delayed at least 15 minutes, as of Jun 25 2024 11:15 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PVP Ventures Limited is an India-based company, which is engaged in the business of health care services and developing urban infrastructure and investments in various ventures. The Company’s segments include Real Estate, Health Care Services and Others. It owns a 70-acre land parcel situated in Chennai and about four kilometers from Chennai central railway station. This land is under joint development with Unitech Limited and Arihant Housing & Foundation Limited. It also owns property in Shamshabad, near International Airport, Hyderabad. The Company focuses on acquisitions and financing arising out of special situations in Indian and global markets. Its subsidiaries include PVP Corporate Parks Private Limited, Safetrunk Services Private Limited, Humain HealthTech Private Limited, Apta Medical Imaging Private Limited and Noble Diagnostics Private Limited.

  • Revenue in INR (TTM)84.73m
  • Net income in INR620.46m
  • Incorporated1991
  • Employees--
  • Location
    PVP Ventures Ltd4th Floor, Punnaiah PlazaPlot No. 83 & 84, Road No. 2Banjara HillsHYDERABAD 500034IndiaIND
  • Phone+91 4 067309999
  • Fax+91 4 067309988
  • Websitehttp://www.pvpglobal.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PVP:NSI since
announced
Transaction
value
Humain Healthtech Pvt LtdDeal completed24 Aug 202324 Aug 2023Deal completed148.79%2.73m
Data delayed at least 15 minutes, as of Jun 25 2024 11:15 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Prozone Realty Ltd1.85bn45.29m4.88bn13.00110.170.957118.302.640.290.2911.7733.380.11730.15813.97--0.1814-0.12160.3076-0.208763.3772.101.55-1.670.57250.74050.3359--6.559.31-82.1013.12-2.81--
PVP Ventures Limited84.73m620.46m7.06bn--11.543.0811.1283.322.352.350.33918.790.02360.00774.43--17.171.1820.062.4383.6880.11726.7610.240.2437-2.560.1576---95.18-25.46-56.84------
Aurum Proptech Ltd2.14bn-557.70m9.01bn80.00--2.33137.804.21-14.16-14.1654.2961.920.4131--10.24---12.7376.97-19.19114.55-----30.82598.49---2.670.6292--68.72-26.36-92.97--24.97--
Oswal Greentech Ltd517.78m63.72m10.14bn81.00164.020.407493.2519.590.24080.24082.0596.940.02040.1340.0762--0.25131.700.25561.7341.50101.7212.31153.6729.89-40.920.0008--171.2421.13-83.18-33.2512.76--
Data as of Jun 25 2024. Currency figures normalised to PVP Ventures Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.